Latest filing published 08 Jul 2026 for Annexin Pharmaceuticals AB (publ), €471k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mikael Lönn: trading record in brief
Mikael Lönn is a declared insider at 2 companies (board member); the most frequent names are Annexin Pharmaceuticals AB (publ) and Genovis AB. We count 9 filings; the first trade dates from 9 May 2019 and the latest from 7 July 2026.
Both buying and selling appear: 3 purchases worth €1.1M, against 4 sales worth €7.5M. Sales outweigh purchases by €6.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants.
A typical purchase (the median) is worth €33k.
The latest filing, published on 8 July 2026, reports a share grant of €471k in Annexin Pharmaceuticals AB (publ). The last insider purchase was made public on 3 July 2024, 858 days ago. Most trades are made public on the day they happen. For comparison, MAR article 19 gives managers three business days to notify a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Mikael Lönn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 435,978 shares@ SEK 12.0028.5% of flowBTA (betald tecknad aktie)ISIN SE0029300896FI:csv-1968a0c13e668f685966
- 255,653 shares@ SEK 25.500.50% mcap52.5% of flowAktieISIN SE0002485979FI:A003O854-1
- 43,251,795 shares@ SEK 0.3071.5% of flowBTA (betald tecknad aktie)ISIN SE0024173066FI:A003M856-1
- 235,000 shares@ SEK 25.500.45% mcap47.5% of flowAktieISIN SE0002485979FI:A003M263-1
- 560,000 shares@ SEK 0.250.5% of flowAktieISIN SE0009664154FI:csv-9d07636d8a621b128b33Canonical exit: 1 Oct 2024 (T+90)
- 1,477,343 shares@ SEK 0.251.2% of flowBTA (betald tecknad aktie)ISIN SE0022087375FI:csv-174ea5c5da50bc332c10Canonical exit: 3 Sept 2024 (T+90)
- 46,652,346 shares@ SEK 0.2537.4% of flowBTA (betald tecknad aktie)ISIN SE0017070865FI:csv-cc64793eb451513d5b19Canonical exit: 26 Aug 2024 (T+90)
- 500,000 shares@ SEK 53.2529.7% of flowAktieISIN SE0002485979FI:csv-3563a6a1c7126dd0ffce
- 2,500,000 shares@ SEK 18.0078.5% of flowAktieISIN SE0002485979FI:csv-19af5897f1907c041d07
9 of 9 declarations